Travere Therapeutics, Inc. (TVTX) — Dilution Risk Analysis

Current Snapshot

Travere Therapeutics, Inc. (TVTX) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
94,261,082 Source
Public Float
86,986,493 Source
Float as % of Outstanding
92.3%

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 10.

FormFiledAccession
4 2026-06-16 0001376043-26-000010
4 2026-05-04 0001680739-26-000007
4 2026-04-23 0001698262-26-000003
4 2026-04-16 0001882909-26-000003
4 2026-04-16 0001680739-26-000005
4 2026-04-16 0001123343-26-000002
4 2026-04-15 0001902368-26-000005
4 2026-04-15 0001283303-26-000008
4 2026-04-15 0001763494-26-000005
4 2026-04-15 0001698262-26-000002

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 5 months Source
Three-year share count growth 25.44% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 50/10) Source
Cash Runway
5 months Source
Share Count Growth (3-Year)
25.44% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.